About Technology Issues FAQ

Links

Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials

Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.